Mitsui Chemicals Inc

MITUY | News | $14.65 -19.3% 110

(0.0% 1d) (-3.9% 1m) (15.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-90.74% volume)
Earnings Calendar:
Market Cap: $ 5,884,723,780
https://www.mitsuichem.com/
Sec Filling | Patents | n/a employees

(JP)

add to watch list Paper trade email alert is off

Portage Biotech Inc

PRTG | $0.285 18.75% 170K

Mining, Quarrying, and Oil and ...

(0.0% 1d) (-51.1% 1m) (-93.3% 1y) (0.0% 2d) (0.0% 3d) (-35.3% 7d) (-1.65% volume)
Earnings Calendar: 2023-11-29
Market Cap: $ 5,073,396
https://portagebiotech.com
Sec Filling | Patents | n/a employees

Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.

add to watch list Paper trade email alert is off

Gold Royalty Corp

GROY | News | $1.925 0.26% 67K

Mining, Quarrying, and Oil and ...

(0.0% 1d) (-0.5% 1m) (-16.3% 1y) (0.0% 2d) (-2.3% 3d) (-2.6% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 280,517,245
https://www.goldroyalty.com
Sec Filling | Patents | 2021 employees

Gold Royalty Corp. is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. Its mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for our investors. GRC's diversified portfolio currently consists of net smelter return royalties ranging from 0.5% to 2.0% on 18 gold properties covering 12 projects located in the Americas.

mining

add to watch list Paper trade email alert is off

Kraig Biocraft Laboratories, Inc

KBLB | $0.088 350K

Mining, Quarrying, and Oil and ...

(0.0% 1d) (-3.2% 1m) (125.0% 1y) (0.0% 2d) (0.0% 3d) (4.5% 7d) (-51.48% volume)
Earnings Calendar:
Market Cap: $ 91,376,931

Sec Filling | Patents | 16 employees

kraig biocraft laboratories, inc. (trading symbol: kblb) is a fully reporting biotechnology company focused on the development and commercialization of spider silks. as a reporting company, our annual and quarterly reports to the sec can be found on edgar and on this website. our investments in genetic research are targeted for product development and innovative near-term solutions to meet the practical problems of our world. our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. we are moving rapidly to commercialize of our spider silk technology, which we believe will have a significant impact on the global textiles industry. at the same time we are continuing to work in cooperation with leading laboratories to create new stronger and more flexible spider silk based fibers with potentially broad appli

add to watch list Paper trade email alert is off